Fintech News 

Hongtai Capital Backs Chinese Biopharma Firm Qyuns Therapeutics In Series B Round

News Source: China Money Network.

Chinese biopharmaceutical firm Qyuns Therapeutics has raised several hundred millions of yuan in a series B round of financing led by Hongtai Capital, a venture capital firm co-established by the founder of Chinese education giant New Oriental Education.

(more…)

Hongtai Capital Backs Chinese Biopharma Firm Qyuns Therapeutics In Series B Round comes originally from Continue Reading the Entire Article Here >>


This news article comes via China Money Network, who is the copyright owner of this information and news. FintekAsia.com has licensed the rights to this article and any republication or re-distribution in whole or in part of this content is strictly prohibited without the express consent of

You May Also Like

JD.com Publishes E-commerce Open Platform Support Plans

BAI Backs Chinese Textile Industry-Focused SaaS Provider Youshupai

Chinese E-Commerce Giant JD.com Unveils $1B Series A Round In Its Healthcare Unit